Dopamine receptor sensitivity in the hypothalamus of chronic schizophrenics after haloperidol therapy: Growth hormone and prolactin response to stimuli

F. Brambilla, L. Bellodi, F. Negri, E. Smeraldi, G. Malagoli

Research output: Contribution to journalArticle

Abstract

(1) The present investigation deals with a study of the hypothalamic dopamine-receptor sensitivity in schizophrenics, before and after haloperidol therapy, examined by investigation of basal GH and PRL levels and responses to an l-DOPA stimulation test. (2) Ten chronic schizophrenics, 8 males and 2 females, aged 27-53 yr, with a duration of illness from 4 to 32 yr, were studied after they were off therapy for at least 10 days. (3) The l-DOPA stimulation test was done at the beginning of the study and again 3 and 6 days after withdrawal of haloperidol which had been administered in increasing doses from 5 to 10 mg a day for 30 days. l-DOPA was given orally at a dose of 500 mg plus carbidopa 100 mg. (4) Patients were tested psychologically before and after haloperidol therapy by the Asberg Psychopathological Rating Scale and typed genetically for the HLA-SD system. (5) Basal prolactin levels before and after haloperidol therapy were low. GH secretion in response to l-DOPA was normal before haloperidol therapy. (6) After treatment the patients could be divided into two groups according to the HLA types; one group showing an increased response to the stimuli as compared with the other. The data are correlated with the psychological effectiveness of the therapy.

Original languageEnglish
Pages (from-to)329-339
Number of pages11
JournalPsychoneuroendocrinology
Volume4
Issue number4
DOIs
Publication statusPublished - 1979

Fingerprint

Dopamine Receptors
Haloperidol
Prolactin
Growth Hormone
Hypothalamus
Therapeutics
Carbidopa
Psychology

Keywords

  • GH
  • haloperidol
  • PRL
  • receptor sensitivity
  • schizophrenia

ASJC Scopus subject areas

  • Endocrinology
  • Endocrinology, Diabetes and Metabolism
  • Psychiatry and Mental health
  • Biological Psychiatry
  • Endocrine and Autonomic Systems
  • Psychology(all)

Cite this

Dopamine receptor sensitivity in the hypothalamus of chronic schizophrenics after haloperidol therapy : Growth hormone and prolactin response to stimuli. / Brambilla, F.; Bellodi, L.; Negri, F.; Smeraldi, E.; Malagoli, G.

In: Psychoneuroendocrinology, Vol. 4, No. 4, 1979, p. 329-339.

Research output: Contribution to journalArticle

@article{e4b218a5ebf9410aa1bfbdb749844189,
title = "Dopamine receptor sensitivity in the hypothalamus of chronic schizophrenics after haloperidol therapy: Growth hormone and prolactin response to stimuli",
abstract = "(1) The present investigation deals with a study of the hypothalamic dopamine-receptor sensitivity in schizophrenics, before and after haloperidol therapy, examined by investigation of basal GH and PRL levels and responses to an l-DOPA stimulation test. (2) Ten chronic schizophrenics, 8 males and 2 females, aged 27-53 yr, with a duration of illness from 4 to 32 yr, were studied after they were off therapy for at least 10 days. (3) The l-DOPA stimulation test was done at the beginning of the study and again 3 and 6 days after withdrawal of haloperidol which had been administered in increasing doses from 5 to 10 mg a day for 30 days. l-DOPA was given orally at a dose of 500 mg plus carbidopa 100 mg. (4) Patients were tested psychologically before and after haloperidol therapy by the Asberg Psychopathological Rating Scale and typed genetically for the HLA-SD system. (5) Basal prolactin levels before and after haloperidol therapy were low. GH secretion in response to l-DOPA was normal before haloperidol therapy. (6) After treatment the patients could be divided into two groups according to the HLA types; one group showing an increased response to the stimuli as compared with the other. The data are correlated with the psychological effectiveness of the therapy.",
keywords = "GH, haloperidol, PRL, receptor sensitivity, schizophrenia",
author = "F. Brambilla and L. Bellodi and F. Negri and E. Smeraldi and G. Malagoli",
year = "1979",
doi = "10.1016/0306-4530(79)90016-7",
language = "English",
volume = "4",
pages = "329--339",
journal = "Psychoneuroendocrinology",
issn = "0306-4530",
publisher = "Elsevier Ltd",
number = "4",

}

TY - JOUR

T1 - Dopamine receptor sensitivity in the hypothalamus of chronic schizophrenics after haloperidol therapy

T2 - Growth hormone and prolactin response to stimuli

AU - Brambilla, F.

AU - Bellodi, L.

AU - Negri, F.

AU - Smeraldi, E.

AU - Malagoli, G.

PY - 1979

Y1 - 1979

N2 - (1) The present investigation deals with a study of the hypothalamic dopamine-receptor sensitivity in schizophrenics, before and after haloperidol therapy, examined by investigation of basal GH and PRL levels and responses to an l-DOPA stimulation test. (2) Ten chronic schizophrenics, 8 males and 2 females, aged 27-53 yr, with a duration of illness from 4 to 32 yr, were studied after they were off therapy for at least 10 days. (3) The l-DOPA stimulation test was done at the beginning of the study and again 3 and 6 days after withdrawal of haloperidol which had been administered in increasing doses from 5 to 10 mg a day for 30 days. l-DOPA was given orally at a dose of 500 mg plus carbidopa 100 mg. (4) Patients were tested psychologically before and after haloperidol therapy by the Asberg Psychopathological Rating Scale and typed genetically for the HLA-SD system. (5) Basal prolactin levels before and after haloperidol therapy were low. GH secretion in response to l-DOPA was normal before haloperidol therapy. (6) After treatment the patients could be divided into two groups according to the HLA types; one group showing an increased response to the stimuli as compared with the other. The data are correlated with the psychological effectiveness of the therapy.

AB - (1) The present investigation deals with a study of the hypothalamic dopamine-receptor sensitivity in schizophrenics, before and after haloperidol therapy, examined by investigation of basal GH and PRL levels and responses to an l-DOPA stimulation test. (2) Ten chronic schizophrenics, 8 males and 2 females, aged 27-53 yr, with a duration of illness from 4 to 32 yr, were studied after they were off therapy for at least 10 days. (3) The l-DOPA stimulation test was done at the beginning of the study and again 3 and 6 days after withdrawal of haloperidol which had been administered in increasing doses from 5 to 10 mg a day for 30 days. l-DOPA was given orally at a dose of 500 mg plus carbidopa 100 mg. (4) Patients were tested psychologically before and after haloperidol therapy by the Asberg Psychopathological Rating Scale and typed genetically for the HLA-SD system. (5) Basal prolactin levels before and after haloperidol therapy were low. GH secretion in response to l-DOPA was normal before haloperidol therapy. (6) After treatment the patients could be divided into two groups according to the HLA types; one group showing an increased response to the stimuli as compared with the other. The data are correlated with the psychological effectiveness of the therapy.

KW - GH

KW - haloperidol

KW - PRL

KW - receptor sensitivity

KW - schizophrenia

UR - http://www.scopus.com/inward/record.url?scp=0018639738&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0018639738&partnerID=8YFLogxK

U2 - 10.1016/0306-4530(79)90016-7

DO - 10.1016/0306-4530(79)90016-7

M3 - Article

C2 - 523590

AN - SCOPUS:0018639738

VL - 4

SP - 329

EP - 339

JO - Psychoneuroendocrinology

JF - Psychoneuroendocrinology

SN - 0306-4530

IS - 4

ER -